Other Stories

COVID-19 trial on hydroxychloroquine resumes after WHO temporarily halted research Updated: 2020-06-04 09:07:59 KST

The World Health Organization says it's resuming its trial of the malaria drug, (High-droxy-CHAW-ROW-QUEEN) hydroxychloroquine to combat COVID-19, after temporarily halting research over safety concerns.
During a press conference on Wednesday, the WHO's chief said the Data Safety Monitoring Board decided there was no reason to discontinue the international trial, after reviewing available data on the drug.
He added the safety board will also continue to closely monitor the safety of other drugs being tested in its trial.
The malaria drug has been in the spotlight since receiving heavy backing by President Trump.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.